- Filed
- Dec 16, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Dec 13, 2024 | 13.82M sh |
| Stock Repurchased | Q2 2025 · Oct 31, 2024 | $0 |
| Stock Repurchased | Q2 2025 · Oct 31, 2023 | $634K |
| Cash And Equivalents | Q2 2025 · Oct 31, 2024 | $2.75M |
| Cash And Equivalents | Q2 2025 · Apr 30, 2024 | $2.62M |
| Stockholders Equity | Q2 2025 · Oct 31, 2024 | $681K |
| Stockholders Equity | Q2 2025 · Jul 31, 2024 | −$332K |
| Stockholders Equity | Q2 2025 · Apr 30, 2024 | −$1.9M |
| Stockholders Equity | Q2 2025 · Oct 31, 2023 | $93K |
| Stockholders Equity | Q2 2025 · Jul 31, 2023 | $1.9M |
| Stockholders Equity | Q2 2025 · Apr 30, 2023 | $4.64M |
| Current Liabilities | Q2 2025 · Oct 31, 2024 | $18.86M |
| Current Liabilities | Q2 2025 · Apr 30, 2024 | $21.54M |
| Total Liabilities | Q2 2025 · Oct 31, 2024 | $24.56M |
| Total Liabilities | Q2 2025 · Apr 30, 2024 | $28.04M |
| Current Assets | Q2 2025 · Oct 31, 2024 | $14.08M |
| Current Assets | Q2 2025 · Apr 30, 2024 | $13.64M |
| Total Assets | Q2 2025 · Oct 31, 2024 | $25.24M |
| Total Assets | Q2 2025 · Apr 30, 2024 | $26.13M |
| Net Income | Q2 2025 · Jul 31, 2024 | $1.31M |
| Net Income | Q2 2025 · Oct 31, 2023 | −$2.07M |
| Net Income | Q2 2025 · Oct 31, 2023 | −$4.64M |
| Net Income | Q2 2025 · Jul 31, 2023 | −$2.57M |
| Shares Diluted | Q2 2025 · Oct 31, 2023 | 13.5M sh |
| Shares Diluted | Q2 2025 · Oct 31, 2023 | 13.53M sh |
| Capex restated | Q2 2025 · Oct 31, 2023 | $747K |
| Operating Cash Flow | Q2 2025 · Oct 31, 2023 | −$3.4M |
| Eps Diluted | Q2 2025 · Oct 31, 2023 | −$0.15 |
| Eps Diluted | Q2 2025 · Oct 31, 2023 | −$0.34 |
| Eps Basic | Q2 2025 · Oct 31, 2023 | −$0.15 |
| Eps Basic | Q2 2025 · Oct 31, 2023 | −$0.34 |
| Sga Expense | Q2 2025 · Oct 31, 2023 | $2.6M |
| Sga Expense | Q2 2025 · Oct 31, 2023 | $5.54M |
| Rd Expense | Q2 2025 · Oct 31, 2023 | $2.52M |
| Rd Expense | Q2 2025 · Oct 31, 2023 | $5.31M |
| Operating Income | Q2 2025 · Oct 31, 2023 | −$1.96M |
| Operating Income | Q2 2025 · Oct 31, 2023 | −$4.51M |
| Cost Of Revenue | Q2 2025 · Oct 31, 2023 | $6.62M |
| Cost Of Revenue | Q2 2025 · Oct 31, 2023 | $14.3M |
| Revenue | Q2 2025 · Oct 31, 2023 | $11.57M |
| Revenue | Q2 2025 · Oct 31, 2023 | $24.13M |